Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D03JSJ
|
|||
| Former ID |
DAP000711
|
|||
| Drug Name |
Mupirocin
|
|||
| Synonyms |
Bactoderm; Bactroban; Centany; MRC; Mupirocina; Mupirocine; Mupirocinum; Plasimine; Bactroban Nasal; Mupirocina [Spanish]; Mupirocine [French]; Mupirocinum [Latin]; Pseudomonic acid; Pseudomonic acid A; BRL 4910A; BRL-4910A; Bactroban (TN); Centany (TN); Mupirocin (USP/INN); Mupirocin, 14C-Labeled; 5,9-Anhydro-2,3,4,8-tetradeoxy-8-[[3-(2-hydroxy-1-methylpropyl)oxiranyl]methyl]-3-methyl-[2E,8[2S,3S(1S,2S); 8-Carboxyoctyl (E)-4-(2S,3R,4R,5S)-5-((2S,3S,4S,5S)-2,3-epoxy-5-hydroxy-4-methylhexyl)-3,4-dihydroxytetrahydro-2H-pyran-2-yl)-3-methylcrotonat; 9-[(E)-4-[(2S,3R,4R,5S)-3,4-dihydroxy-5-[[(2S,3S)-3-[(2S,3S)-3-hydroxybutan-2-yl]oxiran-2-yl]methyl]oxan-2-yl]-3-methylbut-2-enoyl]oxynonanoic acid
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Bacterial infection [ICD-11: 1A00-1C4Z; ICD-10: A00-B99] | Approved | [1] | |
| Therapeutic Class |
Antibiotics
|
|||
| Company |
GlaxoSmithKline
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C26H44O9
|
|||
| Canonical SMILES |
CC(C1C(O1)CC2COC(C(C2O)O)CC(=CC(=O)OCCCCCCCCC(=O)O)C)C(C)O
|
|||
| InChI |
1S/C26H44O9/c1-16(13-23(30)33-11-9-7-5-4-6-8-10-22(28)29)12-20-25(32)24(31)19(15-34-20)14-21-26(35-21)17(2)18(3)27/h13,17-21,24-27,31-32H,4-12,14-15H2,1-3H3,(H,28,29)/b16-13+/t17-,18-,19-,20-,21-,24+,25-,26-/m0/s1
|
|||
| InChIKey |
MINDHVHHQZYEEK-HBBNESRFSA-N
|
|||
| CAS Number |
CAS 12650-69-0
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID |
13922, 823922, 7848139, 7889035, 7980041, 10299925, 12013725, 14859952, 14933324, 24724542, 36888978, 46392321, 46505594, 47193668, 50065315, 50111691, 57404751, 78008293, 93166478, 103196240, 104132238, 104170118, 104636724, 121362555, 124766123, 124800798, 126645581, 134337999, 134991278, 137004041, 144075920, 144205736, 152134175, 160963756, 162172743, 162176723, 163654146, 164814189, 172080743, 175265428, 175611185, 179149750, 184544860, 187072629, 196106879, 223218472, 223391385, 223438264, 223850405, 226395513
|
|||
| ChEBI ID |
CHEBI:7025
|
|||
| ADReCS Drug ID | BADD_D01504 ; BADD_D01505 | |||
| SuperDrug ATC ID |
D06AX09; R01AX06
|
|||
| SuperDrug CAS ID |
cas=012650690
|
|||
| Drug Resistance Mutation (DRM) | Top | |||
|---|---|---|---|---|
| DRM | DRM Info | |||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Bacterial Isoleucyl-tRNA synthetase (Bact ileS) | Target Info | Modulator | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Has nature already identified all useful antibacterial targets Curr Opin Microbiol. 2008 Oct;11(5):387-92. | |||
| REF 2 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.